http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103304561-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate | 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103304561-B |
| titleOfInvention | One class has the compound of anti thrombotic action |
| abstract | The present invention discloses compound and the pharmacy acceptable salt thereof that a class with structure shown in formula I has anti thrombotic action. Wherein, R can be hydrogen, methyl, ethyl, propyl group, sec.-propyl, nitro, cyano group, halogen, trifluoromethyl. The invention also discloses the preparation method of above-claimed cpd, and also disclose using this compound or its pharmacy acceptable salt as the pharmaceutical composition of active effective constituent, and they are as medicament for resisting platelet aggregation, particularly at the coronary syndrome caused because of platelet aggregation for the preparation of prevention or treatment, myocardial infarction, the application of the cardiovascular and cerebrovascular diseases medicament aspects such as myocardial ischemia. |
| priorityDate | 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.